BANK1 Activators are a specialized category of compounds that engage with the B-cell scaffold protein with ankyrin repeats 1 (BANK1) to elevate its functional activity in cellular processes, specifically within the immune system's B-cells. These activators function by influencing signaling pathways that are intricately connected to the physiological role of BANK1, which primarily involves modulating B-cell receptor (BCR) signaling and facilitating the development and function of these immune cells. Notably, BANK1 activators do not directly bind to or alter the structural integrity of the protein but instead work by modulating the cellular environment or interacting with upstream or downstream elements that in turn affect BANK1's activity. For instance, certain phosphoinositide 3-kinase (PI3K) inhibitors can indirectly enhance the function of BANK1 by altering the threshold for BCR signaling, which is a crucial determinant of B-cell activation and survival. By inhibiting competitive signaling pathways or molecules that normally restrain BANK1's activity, these activators ensure that the protein can effectively contribute to the cascade of events that lead to B-cell activation and proper immune function.
In addition to the modulation of kinase activity, other BANK1 activators may influence calcium flux within cells, an event that is known to affect BCR signaling. Compounds that increase intracellular calcium concentration can indirectly facilitate BANK1-mediated signaling by potentiating the pathways that are activated upon BCR engagement. This is achieved without direct interaction with BANK1 but through a broader impact on the cell's signaling machinery, which, in the context of B-cells, would lead to enhanced signaling through BANK1. The specificity of these activators lies in their ability to precisely target the signaling milieu in which BANK1 operates rather than indiscriminately activating various components of the immune response. The enhancement of BANK1 activity by these activators is thus a fine-tuned process, reflecting a deeper understanding of the molecular interplay that governs B-cell functionality. Collectively, BANK1 activators represent a group of compounds that, by modulating specific signaling pathways, contribute to the precise control of B-cell mediated immune responses.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly increases cellular cAMP levels, which subsequently activates PKA (protein kinase A). PKA can phosphorylate several substrates that may include transcription factors that increase the expression and functional activity of BANK1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, mimics cAMP and can activate PKA. Activated PKA can then enhance BANK1 signaling by phosphorylating proteins that interact with BANK1 or BANK1 itself, leading to its functional enhancement. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium concentrations, potentially activating calcium-dependent signaling pathways that can modify the signaling environment in which BANK1 operates, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can modulate signaling pathways involved in BANK1's functional activities. By activating PKC, PMA could influence downstream signaling components that engage BANK1 in immune cell signaling. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol inhibits Syk kinase, which may reduce competitive signaling pathways and allow BANK1-mediated signaling to proceed with less interference, thereby enhancing BANK1's functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenoceptor agonist that elevates cAMP levels, similar to Forskolin, potentially leading to enhanced PKA activity and subsequent activation of signaling cascades that include BANK1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could indirectly enhance BANK1 activity by altering the balance of signaling pathways in cells, potentially favoring the pathways in which BANK1 is involved. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a PKC inhibitor. By selectively inhibiting certain PKC isoforms, it could shift signaling dynamics in favor of BANK1's activity, assuming BANK1 is regulated by PKC-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, similar to Ionomycin, potentially enhancing BANK1 activity by activating calcium-dependent proteins that could interact with BANK1 signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance BANK1 activity by inhibiting a competing pathway, allowing BANK1's associated pathways to become more prominent in signaling within immune cells. | ||||||